A notable example of these developments is Eli Lillys Mounjaro KwikPen, which received approval from India's Central Drugs Standard Control Organization (CDSCO) on June 26, 2025
Because what happens after you stop a GLP-1 medication is not what most people expect, and the consequences of getting it wrong can undo months of progress in a matter of weeks
Semaglutide was originally developed as a once-weekly diabetes medication, meaning millions of people have used it long-term without requiring dose escalation
Keep away from direct light and moisture
Patients may differ in diet, exercise, income, access to care, medication adherence, and disease severity
This unique aspect helps accelerate weight loss beyond what appetite suppression alone can achieve